Key factor for successful therapeutic vaccination against chronic hepatitis B identified: Our colleagues in Munich found that the success of therapeutic hepatitis B vaccination depends on efficient priming of HBV-specific CD4 T cells. The results have been published in the Journal of Hepatology.
In today's episode, our PhD- and MD-students present the integrated graduate school of the TRR. A very varied and informative compilation. Enjoy listening!
The 5th Podcast is a very special edition which gives an impression and snapshots of the international conference, which took place from 29-31.5.2022 in Freiburg. Listen to wraps ups of the highlights of some of our invited speakers ...and feel the spirit of the international research community in the field of viral hepatitis and beyond.
Was autoaggressive T-Zellen böses anrichten können und was wir daraus für die Virushepatitis erkennen
Hört euch an, wie wir unsere bisherige Forschungsexpertise an Hepatitisviren zur Erforschung von SARS-Co-V einsetzen können!